Helen of Troy (HELE) Tops Q4 EPS by 25c, Offers FY20 Guidance

Helen of Troy (NASDAQ: HELE) reported Q4 EPS of $1.82, $0.25 better than the analyst estimate of $1.57. Revenue for the quarter came in at $384.8 million versus the consensus estimate of $364.66 million.

GUIDANCE:

Helen of Troy sees FY2020 EPS of $8.25-$8.50, versus the consensus of $8.07. Helen of Troy sees FY2020 revenue of $1.58-1.611 billion, versus the consensus of $1.56 billion.

For earnings history and earnings-related data on Helen of Troy (HELE) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c